Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emerging trabecular outflow drugs.

Literature DB >> 24304197

Emerging trabecular outflow drugs.

Casey C Kopczynski¹, David L Epstein.

Abstract

Mesh：

Year: 2013 PMID： 24304197 PMCID： PMC3991972 DOI： 10.1089/jop.2013.0197

Source DB: PubMed Journal: J Ocul Pharmacol Ther ISSN： 1080-7683 Impact factor: 2.671

× No keyword cloud information.

11 in total

1. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.

Authors: P V Rao; P F Deng; J Kumar; D L Epstein
Journal: Invest Ophthalmol Vis Sci Date: 2001-04 Impact factor: 4.799

2. Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A.

Authors: H Thieme; M Nuskovski; J U Nass; U Pleyer; O Strauss; M Wiederholt
Journal: Invest Ophthalmol Vis Sci Date: 2000-12 Impact factor: 4.799

3. Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension.

Authors: Hidenobu Tanihara; Toshihiro Inoue; Tetsuya Yamamoto; Yasuaki Kuwayama; Haruki Abe; Makoto Araie
Journal: Am J Ophthalmol Date: 2013-07-04 Impact factor: 5.258

Review 4. Current understanding of conventional outflow dysfunction in glaucoma.

Authors: W Daniel Stamer; Ted S Acott
Journal: Curr Opin Ophthalmol Date: 2012-03 Impact factor: 3.761

Review 5. Pharmacological therapy for glaucoma: a review.

Authors: P F Hoyng; L M van Beek
Journal: Drugs Date: 2000-03 Impact factor: 9.546

6. Intraocular pressure and glaucoma.

Authors: A Sommer
Journal: Am J Ophthalmol Date: 1989-02-15 Impact factor: 5.258

7. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.

Authors: M Honjo; H Tanihara; M Inatani; N Kido; T Sawamura; B Y Yue; S Narumiya; Y Honda
Journal: Invest Ophthalmol Vis Sci Date: 2001-01 Impact factor: 4.799

8. Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.

Authors: Robert D Williams; Gary D Novack; Thomas van Haarlem; Casey Kopczynski
Journal: Am J Ophthalmol Date: 2011-07-27 Impact factor: 5.258

Review 9. Adenosine, adenosine receptors and glaucoma: an updated overview.

Authors: Yisheng Zhong; Zijian Yang; Wei-Chieh Huang; Xunda Luo
Journal: Biochim Biophys Acta Date: 2013-01-15

10. The number of people with glaucoma worldwide in 2010 and 2020.

Authors: H A Quigley; A T Broman
Journal: Br J Ophthalmol Date: 2006-03 Impact factor: 4.638

24 in total

Review 1. Exciting directions in glaucoma.

Authors: Carol A Rasmussen; Paul L Kaufman
Journal: Can J Ophthalmol Date: 2014-12 Impact factor: 1.882

2. α5β1 Integrin Promotes Anchoring and Integration of Transplanted Stem Cells to the Trabecular Meshwork in the Eye for Regeneration.

Authors: Siqi Xiong; Yi Xu; Yiwen Wang; Ajay Kumar; Donna M Peters; Yiqin Du
Journal: Stem Cells Dev Date: 2020-01-20 Impact factor: 3.272

3. The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.

Authors: Arash Kazemi; Jay W McLaren; Casey C Kopczynski; Theresa G Heah; Gary D Novack; Arthur J Sit
Journal: J Ocul Pharmacol Ther Date: 2018-02-22 Impact factor: 2.671

4. Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles.

Authors: Trevor Stack; Amir Vahabikashi; Mark Johnson; Evan Scott
Journal: J Biomed Mater Res A Date: 2018-03-06 Impact factor: 4.396

Review 5. Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors: M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal: Prog Retin Eye Res Date: 2016-09-22 Impact factor: 21.198